About
BY-O1A - The World's First AI-Enabled Automatic Ocular Signometer for Thyroid Eye DiseaseFor decades, TED assessment relied on manual, subjective eye examinations.BY-O1A provides non-contact measurements of eye protrusion, eyelid opening, conjunctival redness and eye movement. Its structured reports deliver objective, quantitative and traceable data to support standardized TED assessment and treatment monitoring.NMPA-registered in China, BY-O1A has received FDA Breakthrough Device Designation and been accepted into FDA TAP. It is in routine clinical use at 50+ tertiary hospitals in China.We are advancing global deployment, with Singapore as our key reference market.